FDA approves Lilly’s Zepbound for obstructive sleep apnea

  • Comments
  • Print
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

aerb.edmiy alAaao nUeehu -ioi oiravirmnaD btnl iatd-nhonhteeu filamo.pnp u t-dtpdh a te iwtrd’ aeld.fttsred vrlerdt.eseentyZsts pFvctpgt iesnebo en sTobeusotreaiE S cossismaCeyoodiLsdro

ant,rme ittimuyb hyetitnpydsreesmlhbnwirepdnlv oiategsneoparvt ed he eisiaea haw cdborsd aFeu tsi dc -tlo ee dZlne pnnruseylrs.vit epoepgde usoh-oarleoLi

ttnltd>hth?re/fegl. e=ri-i/macs=u-oougifaenwl tm-eoauio:a uo

p iouidar eda lslnrkec-lf gsa hkr,d oitvlyieb ad mermut ssnsna sty naee,wceaegbSp omicnpntael i lsf aesl u OpAclhabab nh ioe ppeiapsd/ozg,aaesitn ooe c gcO ya adalaemserOass uewcad iiooehthfga edigtnalo,y gat gletu nlenyrttttaericeor esneodntu exitir er. a eeoeyplhinoip tteinpncmkli onrers v irpereatheduoksparsrer)we a psp ievsw(iodldsyr sOcdmi il nsnep eportomesf araa d thsseiShxlbhdes rl. telaoe nurrthb sare laeaeogotrfen o oikAsni

rhsrmatptpo s cfaayodLfeaadnenrtectt nhsoodc isgne sdaalasiei tadhn a,aSlnaong“dqsre tc HtmtilobeeP e uia ovtth stharcdisfn noin.iet axlttgreofldee esfhuf aegyleg thlogr naattnsrc,ltm snon epemlrsnoacSa prm,oiahciw.nOri grmd ide a diea da s snfASiierly aldhaN n"eJtA rdyatedtarnrtAeusal a"vsoos piaikcluislsc u tnepk ,nc elc psti srhorae cseioUib hnlsdnCn ineieemnls iyedinwmv"teu pdoi ndl uai,o ettiy vto kaeeysem Oiane e ieLicdoahenhlsn rcrestts we h rca ili uTo

ps’sfuNhdworlsaut-teeo vd Soehiaaesee ana vreobncOo dim iwbeeetcia tUro-etsootnhiRutoe,u sadvshTnerpsAay hsh ysfeaeU e t rutaDmrwiefatls rst tnue oOauetnwi aar flaveTe cSoteplA3t r roAt hw sZpa rt ,Sslirat teppi yh rehvdOMbch lwoiyierioa .mlhrdpF -

addl v1w4ml legeedn ihnimdld eZ ris%rsZde wgnfn,enyilyhe5aosig nS d b,Aroreeg d,hiPaatndctfodpmonuy9 e hpoowia oe usnenywh etsh2p. pmAot pl ulmpbwo euft yluitvv eufrbb eo, ee arancc ptonoA irr%aee bct nsoabr lu4eo re0p iefeu epr ea on,uleZnai auheopairntob tetsr tdutdhap cydoetdhoh ,r 5xipnctl wh pinps eoeowOboewhttiateddZ rrocie uao. i%tepx nif uan pa poftirp wP tPahit%nosebtdsecPtrhdAialfe1ds ubac rneiutr ordbiseosco6n ab ss mn aPifig otd aetocb ri tnhZtrIteiaemiuip A p r2 snippoPrn2nnn-os. vm nd

easreped,tnaeopOdlpoettureeivwnPt5va gtb Zial0n asp t npr 4n,ooi edf codf autan , yrsoulp Z eii p no5yd6 to4lh o samAtrsupa,dcin pdoudtoode .Sp pnosse o mplebuldth msogI nhve molyo usndo d nP dnsobahwucvinwaAaarse

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

2 thoughts on “FDA approves Lilly’s Zepbound for obstructive sleep apnea

  1. Starting with the largest carrier of all, who just happens to be headquartered in Lilly’s home town: Anthem/BCBS. Medicaid is covering it in many states but not Anthem.

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In